Business

Granules India Q2 net profit surges 71% to Rs 164 cr

Updated : October 21, 2020 09:11 AM IST

Drug firm Granules India on Tuesday reported a 70.82 percent rise in its consolidated net profit to Rs 163.63 crore for the second quarter ended September 30, mainly on account of robust sales. The company had posted a net profit of Rs 95.79 crore for the corresponding period previous fiscal, Granules India said in a BSE filing.

Consolidated revenue from operations stood at Rs 858.12 crore for the quarter under consideration. It was Rs 699.53 crore in the same period a year ago, it added.

"I am pleased to announce a second consecutive robust performance by all our business segments, fuelled the 22.7 percent growth in Q2FY21 revenues to Rs 858 crore," Granules India Chairman and MD Krishna Prasad Chigurupati said.

The company's Board has declared a second interim dividend of 25 paise per equity share of Re 1 each, the filing said. Shares of Granules India Ltd were trading at Rs393.55 per scrip on BSE, up 0.54 percent from its previous close.

Granules India Q2 net profit surges 71% to Rs 164 cr

You May Also Like

Coronavirus Latest Updates: 9,102 new COVID-19 cases in India, 117 more deaths; active cases at 1,77,266

Mahanadi Coal Railway scouts for CEO to rollout Rs 1,700 crore project

Delhi-NCR has maximum stuck housing units at 1.9 lakh worth nearly Rs 1.2 lakh cr: Report

Trending on CNBC-TV18

recommended for you